Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-009968·Ernexa Therapeutics Inc.
Schedule 13G ownership disclosure
ETERNA THERAPEUTICS INC
Common stock, par value $0.005 per share · CUSIP: 114082209
Event date: 2024-10-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Freebird Partners LP
Shares: 5,136,696 · Class: 9.99%
- Freebird Investments LLC
Shares: 5,136,696 · Class: 9.99%
- Curtis Huff
Shares: 5,136,696 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-009968
- Form type
- SCHEDULE 13G/A
- Filer
- Ernexa Therapeutics Inc.
- CIK
- CIK 748592
- Filed
- Jan 28, 2025
- Reporting period
- Oct 29, 2024
- Description
- Schedule 13G beneficial ownership